Nigeria Neurology Devices Market Report 2022 to 2030

Nigeria Neurology Devices Market Analysis

$ 3999

The Nigeria Neurology Device Market is expected to witness growth from $11 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The Prevalence of Neurological illnesses has increased in Nigeria, which results in increasing demand for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Me Cure Healthcare, Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.

ID: IN10NGMD012 CATEGORY: Medical Devices GEOGRAPHY: Nigeria AUTHOR: Jigyasu Bhandari

Buy Now

Nigeria Neurology Devices Market Executive Analysis

The Nigeria Neurology Devices Market size is at around $11 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. In Nigeria, the amount of money set aside for health care as a percentage of the overall budget is declining, falling from 11.2% in 2020 to 8.6% in 2022. In Nigeria, per capita, health spending decreased from $10.8 per person in 2020 to $8.5 per person per year in 2022. The total share of capital allocated to Nigeria's health sector between 2020 and 2022 varied just slightly, between 49.8% and 53.9%.

Nigeria has a 1.5% prevalence of Parkinson's disease. 2.2% of the population in Nigeria suffers from epilepsy. Stroke, meningitis, encephalitis, peripheral neuropathy, and other neurological diseases are very common in Nigeria. Nigeria has one of the highest rates of stroke occurrence in the world, and stroke is a major cause of death and disability there. The provision of healthcare services and resources may also have an effect on Nigeria's prevalence and incidence rates for neurological diseases and disorders. Whereas interventional devices use radiography and catheters to diagnose the patient's ailments, deep brain stimulation devices assist in carrying out therapies by implanting a neurology device that provides electrical impulses to particular target regions in the brain. Neurology devices are used to diagnose, treat, and prevent a wide range of neurological conditions, such as Alzheimer's disease, spinal cord injuries, and traumatic brain injuries. These neurological devices are also used to help persons regain their hearing and vision who have lost a limb or who have congenital limb discrepancies.

Nigeria Neurology Device Market Analysis

Market Dynamics

Market Growth Drivers

The Prevalence of Neurological illnesses has increased in Nigeria, which results in increasing demand for neurology devices. The population is ageing, habits are changing, and there are environmental issues to blame for this. The creation of more sophisticated and advanced neurology devices, including implanted devices, neurostimulation devices, and improved imaging systems, is a result of technological advancements. Due to their improved diagnostic and therapeutic capabilities, these neurology devices are in more demand in the market.

Market Restraints

Manufacturers of Neurology devices may find the regulatory environment in Nigeria difficult because of the difficult and drawn-out registration and approval procedures. Because of this, it could be challenging for manufacturers to launch their innovative neurology devices quickly.

Competitive Landscape

Key Players

Me Cure Healthcare (NG)
Philips Healthcare
Medtronic
Abbott Laboratories
Johnson & Johnson
Boston Scientific
GE Healthcare

Notable Recent Deals

2022: The Nigerian Ministry of Health and Philips Healthcare inked a contract in 2022 for the provision of a variety of neurology devices. Through this agreement, patients in Nigeria will receive higher-quality care and have easier access to cutting-edge medical technologies.

2021: In order to supply cutting-edge medical imaging and neurology devices, GE Healthcare signed a contract in 2021 with Synlab Nigeria, a top provider of medical diagnostic services. The diagnosis and treatment of neurological disorders in Nigeria will be a qualitative part of this agreement.

Healthcare Policies and Regulatory Landscape

The Nigerian Medical Products Regulatory Agency (NMPRA), which is in charge of the registration and regulation of medical devices, has a Medical Devices Section that oversees neurology devices. Before their devices can be sold in Nigeria, manufacturers of neurology devices must have regulatory approval from the NMPRA. In Nigeria, the manufacture, importation, exportation, distribution, advertisement, and sale of neurological devices are regulated and controlled by the National Agency for Food and Drug Administration and Control (NAFDAC). Before any neurology devices are made available on the Nigerian market, NAFDAC verifies their efficacy and safety. The National Health Act, which was enacted into law in 2014, serves as Nigeria's complete regulatory and service delivery framework. The law calls for the creation of a National Health Insurance System (NHIS), which facilitates greater access to medical treatments, including devices for neurology.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
?Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

??Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.